No Data
No Data
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor Drug Pipeline Market 2024 Featuring Vanda Pharmaceuticals, Novartis, Vernalis, Levolta Pharmaceuticals, & Vertex Pharmaceuticals
Sector Update: Health Care Stocks Softer Thursday Afternoon
Health care stocks fell Thursday afternoon with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.3%. The iShares Biotechnology ETF (IBB) fell 0.4%. I
Express News | Vanda Pharmaceuticals Shares Extend Gains, Last up 13.4%
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday.Shares of Tesla Inc (NASDAQ:TSLA) rose sharply during Thursday's session after CEO Elon Musk said the company's s
Express News | Vanda Pharmaceuticals Receives Revised Unsolicited Acquisition Proposal From Future Pak For $8.50-$9.00 Per Share In Cash Plus Contingent Value Rights; No Shareholder Action Required At This Time
Express News | Vanda Pharmaceuticals Inc - Board Will Carefully Review and Evaluate Revised, Non-Binding Proposal
No Data